[{"Assets_0_FY_USD":89093000.0,"EarningsPerShareBasic_1_FY_USD":-0.19,"EarningsPerShareBasic_4_FY_USD":-0.31,"EarningsPerShareDiluted_1_FY_USD":-0.19,"EarningsPerShareDiluted_4_FY_USD":-0.31,"NetIncomeLoss_1_FY_USD":-4136000.0,"NetIncomeLoss_4_FY_USD":-6227000.0,"StockholdersEquity_0_FY_USD":-215048000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":19816635.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":19816635.0,"Ticker":"RETA","CIK":"1358762","name":"REATA PHARMACEUTICALS INC","OfficialName":"Reata Pharmaceuticals Inc. Class A Common Stock","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1148907684.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170303"}]